Baicalein inhibits PRRSV through direct binding, targeting EGFR, and enhancing immune response

Abstract Porcine reproductive and respiratory syndrome virus (PRRSV) presents significant economic challenges to the global pork industry due to its ability to mutate rapidly. The current commercial vaccines have limited effectiveness, and there are strict restrictions on the use of antiviral chemic...

Full description

Saved in:
Bibliographic Details
Main Authors: Jing Wu, Qi Lu, Jing Hou, Yueqin Qiu, Min Tian, Li Wang, Kaiguo Gao, Xuefen Yang, Zongyong Jiang
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Veterinary Research
Subjects:
Online Access:https://doi.org/10.1186/s13567-024-01440-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585439973736448
author Jing Wu
Qi Lu
Jing Hou
Yueqin Qiu
Min Tian
Li Wang
Kaiguo Gao
Xuefen Yang
Zongyong Jiang
author_facet Jing Wu
Qi Lu
Jing Hou
Yueqin Qiu
Min Tian
Li Wang
Kaiguo Gao
Xuefen Yang
Zongyong Jiang
author_sort Jing Wu
collection DOAJ
description Abstract Porcine reproductive and respiratory syndrome virus (PRRSV) presents significant economic challenges to the global pork industry due to its ability to mutate rapidly. The current commercial vaccines have limited effectiveness, and there are strict restrictions on the use of antiviral chemical drugs. Therefore, it is urgent to identify new strategies for preventing and controlling PRRSV infections. Baicalein, a flavonoid derived from Scutellaria baicalensis, has gained attention for its potential antiviral properties. However, there is little information about the effects and mechanisms of baicalein in relation to PRRSV. In this study, a network pharmacology analysis identified seven potential targets of baicalein against PRRSV, with the epidermal growth factor receptor (EGFR) emerging as the core target. The results of molecular docking and dynamics (MD) simulations confirmed that baicalein has a high binding affinity for EGFR, with a measured value of − 7.935 kcal/mol. Additionally, both in vitro (EC50 = 10.20 μg/mL) and in vivo (2.41 mg/kg) experiments were conducted to assess the effectiveness of baicalein against PRRSV. Notably, baicalein was found to inhibit various stages of the PRRSV replication cycle and could directly bind to PRRSV in vitro. Baicalein inhibited the entry of PRRSV by blocking EGFR phosphorylation and the downstream PI3K-AKT signaling pathway. This was confirmed by a decrease in the expression of p-EGFR/EGFR, p-AKT/AKT, PI3K, and SRC following treatment with baicalein. Additionally, baicalein significantly enhanced the immune response in piglets infected with PRRSV. In conclusion, this study suggests that baicalein may be a promising pharmaceutical candidate for preventing and controlling PRRS, offering new insights into the antiviral potential of Chinese herbal medicine.
format Article
id doaj-art-944acc229d0d433f9bda8e20db490da6
institution Kabale University
issn 1297-9716
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Veterinary Research
spelling doaj-art-944acc229d0d433f9bda8e20db490da62025-01-26T12:47:50ZengBMCVeterinary Research1297-97162025-01-0156112010.1186/s13567-024-01440-5Baicalein inhibits PRRSV through direct binding, targeting EGFR, and enhancing immune responseJing Wu0Qi Lu1Jing Hou2Yueqin Qiu3Min Tian4Li Wang5Kaiguo Gao6Xuefen Yang7Zongyong Jiang8Institute of Animal Science, Guangdong Academy of Agricultural SciencesInstitute of Animal Science, Guangdong Academy of Agricultural SciencesInstitute of Animal Science, Guangdong Academy of Agricultural SciencesInstitute of Animal Science, Guangdong Academy of Agricultural SciencesInstitute of Animal Science, Guangdong Academy of Agricultural SciencesInstitute of Animal Science, Guangdong Academy of Agricultural SciencesInstitute of Animal Science, Guangdong Academy of Agricultural SciencesInstitute of Animal Science, Guangdong Academy of Agricultural SciencesInstitute of Animal Science, Guangdong Academy of Agricultural SciencesAbstract Porcine reproductive and respiratory syndrome virus (PRRSV) presents significant economic challenges to the global pork industry due to its ability to mutate rapidly. The current commercial vaccines have limited effectiveness, and there are strict restrictions on the use of antiviral chemical drugs. Therefore, it is urgent to identify new strategies for preventing and controlling PRRSV infections. Baicalein, a flavonoid derived from Scutellaria baicalensis, has gained attention for its potential antiviral properties. However, there is little information about the effects and mechanisms of baicalein in relation to PRRSV. In this study, a network pharmacology analysis identified seven potential targets of baicalein against PRRSV, with the epidermal growth factor receptor (EGFR) emerging as the core target. The results of molecular docking and dynamics (MD) simulations confirmed that baicalein has a high binding affinity for EGFR, with a measured value of − 7.935 kcal/mol. Additionally, both in vitro (EC50 = 10.20 μg/mL) and in vivo (2.41 mg/kg) experiments were conducted to assess the effectiveness of baicalein against PRRSV. Notably, baicalein was found to inhibit various stages of the PRRSV replication cycle and could directly bind to PRRSV in vitro. Baicalein inhibited the entry of PRRSV by blocking EGFR phosphorylation and the downstream PI3K-AKT signaling pathway. This was confirmed by a decrease in the expression of p-EGFR/EGFR, p-AKT/AKT, PI3K, and SRC following treatment with baicalein. Additionally, baicalein significantly enhanced the immune response in piglets infected with PRRSV. In conclusion, this study suggests that baicalein may be a promising pharmaceutical candidate for preventing and controlling PRRS, offering new insights into the antiviral potential of Chinese herbal medicine.https://doi.org/10.1186/s13567-024-01440-5PigletsPRRSVbaicaleinEGFRMD simulation
spellingShingle Jing Wu
Qi Lu
Jing Hou
Yueqin Qiu
Min Tian
Li Wang
Kaiguo Gao
Xuefen Yang
Zongyong Jiang
Baicalein inhibits PRRSV through direct binding, targeting EGFR, and enhancing immune response
Veterinary Research
Piglets
PRRSV
baicalein
EGFR
MD simulation
title Baicalein inhibits PRRSV through direct binding, targeting EGFR, and enhancing immune response
title_full Baicalein inhibits PRRSV through direct binding, targeting EGFR, and enhancing immune response
title_fullStr Baicalein inhibits PRRSV through direct binding, targeting EGFR, and enhancing immune response
title_full_unstemmed Baicalein inhibits PRRSV through direct binding, targeting EGFR, and enhancing immune response
title_short Baicalein inhibits PRRSV through direct binding, targeting EGFR, and enhancing immune response
title_sort baicalein inhibits prrsv through direct binding targeting egfr and enhancing immune response
topic Piglets
PRRSV
baicalein
EGFR
MD simulation
url https://doi.org/10.1186/s13567-024-01440-5
work_keys_str_mv AT jingwu baicaleininhibitsprrsvthroughdirectbindingtargetingegfrandenhancingimmuneresponse
AT qilu baicaleininhibitsprrsvthroughdirectbindingtargetingegfrandenhancingimmuneresponse
AT jinghou baicaleininhibitsprrsvthroughdirectbindingtargetingegfrandenhancingimmuneresponse
AT yueqinqiu baicaleininhibitsprrsvthroughdirectbindingtargetingegfrandenhancingimmuneresponse
AT mintian baicaleininhibitsprrsvthroughdirectbindingtargetingegfrandenhancingimmuneresponse
AT liwang baicaleininhibitsprrsvthroughdirectbindingtargetingegfrandenhancingimmuneresponse
AT kaiguogao baicaleininhibitsprrsvthroughdirectbindingtargetingegfrandenhancingimmuneresponse
AT xuefenyang baicaleininhibitsprrsvthroughdirectbindingtargetingegfrandenhancingimmuneresponse
AT zongyongjiang baicaleininhibitsprrsvthroughdirectbindingtargetingegfrandenhancingimmuneresponse